Digoxin Treatment Reverses Angiogenic Switch During HeartMate 3 Support and is Associated with Decrease Risk for Gastrointestinal Bleeding.
The journal of heart and lung transplantation/The Journal of heart and lung transplantation(2020)
Abstract
Digoxin, an inhibitor of HIF1-α signaling cascade, may contribute to a lower risk of GIB in HM3 patients by restoring angiogenic equilibrium.
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined